We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$8.14B
AUM Growth
+$473M
Cap. Flow
+$1.3B
Cap. Flow %
15.91%
Top 10 Hldgs %
18.35%
Holding
1,253
New
376
Increased
261
Reduced
225
Closed
366

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
2
ZTS icon
Zoetis
ZTS
+$103M
3
GILD icon
Gilead Sciences
GILD
+$98.1M
4
SHW icon
Sherwin-Williams
SHW
+$85.9M
5
VZ icon
Verizon
VZ
+$79.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Financials 15.39%
3 Communication Services 14.58%
4 Consumer Discretionary 9.63%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTCT
376
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$2.9M 0.04%
119,612
-75,239
-39% -$1.97M
MCRN
377
DELISTED
Milacron Holdings Corp.
MCRN
$2.9M 0.04%
165,018
-472,282
-74% -$8.95M
VC icon
378
Visteon
VC
$2.75B
$2.89M 0.04%
28,590
+24,037
+528% +$2.42M
SM icon
379
SM Energy
SM
$6.88B
$2.88M 0.04%
+90,030
New +$3.27M
THOR
380
DELISTED
THORATEC CORPORATION
THOR
$2.88M 0.04%
45,599
-24,324
-35% -$1.45M
RLI icon
381
RLI Corp
RLI
$5.91B
$2.86M 0.04%
+106,994
New +$2.9M
PPC icon
382
Pilgrim's Pride
PPC
$6.56B
$2.84M 0.03%
+136,841
New +$2.94M
TDG icon
383
TransDigm Group
TDG
$69.8B
$2.83M 0.03%
13,311
+3,090
+30% +$707K
SPN
384
DELISTED
Superior Energy Services, Inc.
SPN
$2.82M 0.03%
+22,356
New +$3.65M
MACK
385
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.8M 0.03%
41,862
-20,967
-33% -$1.71M
IPHS
386
DELISTED
Innophos Holdings, Inc.
IPHS
$2.8M 0.03%
70,694
+61,720
+688% +$2.99M
EMN icon
387
Eastman Chemical
EMN
$8.4B
$2.78M 0.03%
42,954
-231,601
-84% -$17.1M
PE
388
DELISTED
PARSLEY ENERGY INC
PE
$2.77M 0.03%
+183,902
New +$2.86M
CBM
389
DELISTED
Cambrex Corporation
CBM
$2.76M 0.03%
+69,459
New +$3.25M
MDP
390
DELISTED
Meredith Corporation
MDP
$2.75M 0.03%
+64,600
New +$3.08M
INFN
391
DELISTED
Infinera Corporation Common Stock
INFN
$2.75M 0.03%
+140,611
New +$3.06M
GSK icon
392
GSK
GSK
$104B
$2.73M 0.03%
+56,867
New +$2.96M
BXLT
393
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$2.67M 0.03%
+84,852
New +$2.93M
CRI icon
394
Carter's
CRI
$1.48B
$2.67M 0.03%
+29,494
New +$2.96M
CABO icon
395
Cable One
CABO
$252M
$2.65M 0.03%
+6,312
New +$2.61M
NCLH icon
396
Norwegian Cruise Line
NCLH
$8.89B
$2.63M 0.03%
45,925
+22,080
+93% +$1.3M
ALTO icon
397
Alto Ingredients
ALTO
$350M
$2.63M 0.03%
404,632
+387,591
+2,274% +$2.96M
NUVA
398
DELISTED
NuVasive, Inc.
NUVA
$2.62M 0.03%
+54,296
New +$2.81M
LQDT icon
399
Liquidity Services
LQDT
$1.31B
$2.6M 0.03%
+352,565
New +$2.93M
BWA icon
400
BorgWarner
BWA
$13.4B
$2.6M 0.03%
+71,130
New +$2.96M

Similar funds

Marshall Wace's Q3 2015 Portfolio in Review

As of Q3 2015, Marshall Wace held 1,253 positions worth $8.14B, up 6.2% from $7.67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.3B of net new capital in Q3 2015, opening 376 new positions and adding to 261 existing holdings. Its largest new stake was Alphabet (Google) Class A: 5,575,920 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $137M trimmed.

  • Marshall Wace's largest Q3 2015 buy was Alphabet (Google) Class A: 5,575,920 shares worth $178M.
  • Marshall Wace added most to Zoetis in Q3 2015, an estimated $103M increase.
  • Marshall Wace's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $137M.
  • Marshall Wace fully exited Emerson Electric in Q3 2015, selling an estimated $46.3M.
  • Marshall Wace's ten largest holdings make up 18% of its $8.14B portfolio in Q3 2015.
  • Marshall Wace opened 376 new positions and closed 366 in Q3 2015.
  • Marshall Wace's portfolio value rose 6.2% quarter-over-quarter to $8.14B.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.